Mustafa Yılmaz

Mustafa Yılmaz


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
ATAyça Tuzcu
Ayça Tuzcu
KYKenan Yörük
Kenan Yörük
YKYusuf Kurtulmus
Yusuf Kurtulmus
MYMustafa Yılmaz
Mustafa Yılmaz
Background/Objectives: The erythrocyte sedimentation rate (ESR) is a widely used biomarker of systemic inflammation, with established roles in rheumatologic, infectious, and malignant disease. The Westergren method remains the reference procedure, but automated analyzers are increasingly used clinically, and methodological differences may introduce systematic bias. This study evaluated analytical agreement between the Vision C automated ESR analyzer (EDTA) and the Westergren reference (sodium citrate). Methods: This prospective, single-center study followed CLSI EP09-ED3. A total of 228 consecutive adult patients were enrolled. Agreement was assessed by Bland–Altman analysis, Passing–Bablok regression, and Pearson correlation, with subgroup analyses (80 mm/h) and against RCPA allowable total error (TEa) specifications. Results: Bland–Altman analysis showed a significant mean bias of −3.30 mm/h (95% CI: −4.25 to −2.35), with increasing dispersion at higher ESR values indicating heteroscedasticity; regression-based limits of agreement therefore widened progressively with ESR magnitude. Passing–Bablok regression showed no proportional bias but a significant constant bias; subgroup regression was not performed due to truncated ranges. Correlation was strong overall (r = 0.961, p < 0.001) and declined across subgroups (r = 0.821, 0.740, 0.687), consistent with range restriction rather than reduced agreement. The analyzer met RCPA TEa criteria across both ranges (≤20 mm/h: bias −2.55 mm/h within ±6.0 mm/h; >20 mm/h: percentage bias −10.49% within ±30%), including the high-ESR subgroup (approximately 6–9%). Conclusions: The Vision C analyzer showed a significant, level-dependent negative bias versus Westergren, widening at higher ESRs; strong correlation and RCPA TEa compliance across the full range, including the high subgroup, support its suitability for routine use. Wide regression-based limits and the limited high subgroup sample size (n = 20) warrant caution and further study but do not support routine manual confirmation, since predefined acceptance criteria are met. Method-specific reporting and consistent instrument use in follow-up are recommended.

9 September 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
ATAyça Tuzcu
Ayça Tuzcu
MGMustafa Gok
Mustafa Gok
KYKenan Yörük
Kenan Yörük
MYMustafa Yılmaz
Mustafa Yılmaz
AAAli Alkaşı
Ali Alkaşı
GTGöksel Tuzcu
Göksel Tuzcu
Background/Objectives: Alpha-Klotho is a circulating protein with anti-aging and vasculoprotective properties that may play a role in vascular calcification. This study aimed to investigate the association between serum alpha-Klotho levels and coronary atherosclerotic burden assessed by the Agatston score and CAD-RADS grading, as well as cardiometabolic risk indices. Methods: This single-center, prospective, cross-sectional study included 86 patients undergoing coronary computed tomography angiography. Serum alpha-Klotho levels were measured by ELISA. Associations with imaging and metabolic variables were assessed using Spearman correlation and age-adjusted partial correlation analyses. Independent associations were evaluated using multivariable linear regression with HC3-robust standard errors. Binary and ordinal logistic regression models with CAD-RADS as the dependent variable and receiver operating characteristic (ROC) analysis were additionally performed. Results: Serum Klotho levels were negatively correlated with age (ρ = −0.598), Agatston score (ρ = −0.540), and CAD-RADS (ρ = −0.549) (all p < 0.001). Associations with the Agatston score and CAD-RADS remained significant after age adjustment (ρ = −0.348 and −0.352, respectively). AIP also remained independently associated with Klotho after age adjustment (ρ = −0.289, p = 0.007), whereas associations with TyG and METS-IR were attenuated. Multivariable models explained 50–52% of the variance in Klotho. In ordinal logistic regression, Klotho remained independently associated with CAD-RADS severity after adjustment for age, sex, BMI, and AIP (OR = 0.525, p = 0.033). ROC analysis demonstrated moderate discrimination for the presence of coronary atherosclerosis, defined as Agatston score > 0 (equivalently, CAD-RADS > 0 in this cohort) (AUC = 0.754, 95% CI 0.654–0.855); an exploratory, internally derived cutoff of ≤823 pg/mL—not a clinically validated threshold—yielded 72.0% sensitivity and 75.0% specificity (bootstrap-validated optimism-corrected: 69.3% and 72.5%). Conclusions: Lower serum alpha-Klotho levels were independently associated with greater coronary atherosclerotic burden and showed moderate discriminative ability for its presence. These findings are preliminary and support further investigation of alpha-Klotho as a candidate circulating biomarker of coronary atherosclerosis, pending validation in larger, prospective cohorts.

1 September 2026 in Metabolites
Verified
Journal Article
Open access
PDF file
ATAyça Tuzcu
Ayça Tuzcu
CKCem Kaba
Cem Kaba
AAArzu Ateş
Arzu Ateş
KYKenan Yörük
Kenan Yörük
MYMustafa Yılmaz
Mustafa Yılmaz
GTGöksel Tuzcu
Göksel Tuzcu
Background/Objectives: The extent to which inhibin B, a marker of Sertoli cell function, is affected by cardiometabolic disturbances remains insufficiently understood. The aim of this study was to evaluate the relationships between serum inhibin B levels and the atherogenic index of plasma (AIP), triglyceride–glucose (TyG) index, HOMA-IR, METS-IR, and C-reactive protein (CRP) in adult men aged 40–65 years and to secondarily investigate a possible association with coronary artery calcium score (CACS). Methods: This cross-sectional study included 67 men aged 40–65 years referred for coronary computed tomography angiography, sampled in a balanced manner across coronary artery calcium score (CACS) categories. Serum inhibin B levels were measured by a commercial sandwich ELISA; AIP, TyG index, HOMA-IR, and METS-IR were calculated from fasting biochemical measurements. Associations between inhibin B and cardiometabolic parameters were assessed using Spearman correlation analyses and age-adjusted partial correlations. Significant associations were further examined using multivariable linear regression. Results: The mean serum inhibin B level was 224 ± 35 pg/mL. The TyG index (ρ = −0.308, p = 0.011) and BMI (ρ = −0.348, p = 0.004) showed significant negative correlations with inhibin B, and both associations persisted after age adjustment. No significant associations were found with HOMA-IR, METS-IR, AIP, CRP, or CACS. Although BMI and the TyG index were not significantly correlated with each other (ρ = −0.084, p = 0.564), both variables remained independently associated with inhibin B in the multivariable model (TyG: β = −0.283, p = 0.015; BMI: β = −0.313, p = 0.007). The model explained 18.0% of the variance in inhibin B (R2 = 0.180). Conclusions: In adult men, serum inhibin B levels were independently and inversely associated with BMI and the TyG index, whereas no significant relationship was observed with other metabolic, inflammatory, atherogenic, or coronary calcification markers. These findings suggest that the relationship between inhibin B and cardiometabolic health is not generalizable across all cardiometabolic indices and may be specifically related to the metabolic profile represented by adiposity and the TyG index.